CVS Health (CVS) concluded the recent trading session at $61.37, signifying a +0.61% move from its prior day's close.
CTO Tilak Mandadi is juggling a complex business with many different units.
Drugstore giant CVS faces numerous bearish headwinds, which are industry and company-specific. Investors should avoid shares over the next 6-12 months.